HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/5/G959    most recent 00154.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (15) Citing Articles via Google Scholar Google Scholar Articles by Wick, E. C. Articles by Kirkwood, K. S. Search for Related Content PubMed PubMed Citation Articles by Wick, E. C. Articles by Kirkwood, K. S.

INFLAMMATION/IMMUNITY/MEDIATORS

Transient receptor potential vanilloid 1, calcitonin gene-related peptide, and substance P mediate nociception in acute pancreatitis

Departments of Surgery and Physiology, University of California, San Francisco, California

Submitted 1 April 2005 ; accepted in final form 23 December 2005

The mechanism of pancreatitis-induced pain is unknown. In other tissues, inflammation activates transient receptor potential vanilloid 1 (TRPV1) on sensory nerves to liberate CGRP and substance P (SP) in peripheral tissues and the dorsal horn to cause neurogenic inflammation and pain, respectively. We evaluated the contribution of TRPV1, CGRP, and SP to pancreatic pain in rats. TRPV1, CGRP, and SP were coexpressed in nerve fibers of the pancreas. Injection of the TRPV1 agonist capsaicin into the pancreatic duct induced endocytosis of the neurokinin 1 receptor in spinal neurons in the dorsal horn (T10), indicative of SP release upon stimulation of pancreatic sensory nerves. Induction of necrotizing pancreatitis by treatment with L-arginine caused a 12-fold increase in the number of spinal neurons expressing the proto-oncogene c-fos in laminae I and II of L1, suggesting activation of nociceptive pathways. L-Arginine also caused a threefold increase in spontaneous abdominal contractions detected by electromyography, suggestive of referred pain. Systemic administration of the TRPV1 antagonist capsazepine inhibited c-fos expression by 2.5-fold and abdominal contractions by 4-fold. Intrathecal, but not systemic, administration of antagonists of CGRP (CGRP_8–37) and SP (SR140333) receptors attenuated c-fos expression in spinal neurons by twofold. Thus necrotizing pancreatitis activates TRPV1 on pancreatic sensory nerves to release SP and CGRP in the dorsal horn, resulting in nociception. Antagonism of TRPV1, SP, and CGRP receptors may suppress pancreatitis pain.

hyperalgesia; inflammation; neurokinin receptors; visceral pain

This article has been cited by other articles:

				A. B Nagar and F. Gorelick Prevention of post-ERCP pancreatitis: a little antacid might go a long way Gut, November 1, 2008; 57(11): 1492 - 1493. [Full Text] [PDF]

				A M Drewes, A L Krarup, S Detlefsen, M-L Malmstrom, G Dimcevski, and P Funch-Jensen Pain in chronic pancreatitis: the role of neuropathic pain mechanisms Gut, November 1, 2008; 57(11): 1616 - 1627. [Abstract] [Full Text] [PDF]

				B. Nilius, G. Owsianik, T. Voets, and J. A. Peters Transient Receptor Potential Cation Channels in Disease Physiol Rev, January 1, 2007; 87(1): 165 - 217. [Abstract] [Full Text] [PDF]

				F F di Mola, H Friess, J Koninger, F Selvaggi, I Esposito, M W Buchler, and P di Sebastiano Haemorrhoids and transient receptor potential vanilloid 1. Gut, November 1, 2006; 55(11): 1665 - 1666. [Full Text] [PDF]